First human test for new kidney drug
NCT ID NCT02837237
Summary
This early-stage study aimed to check the safety and how the body processes a new oral drug called KBP-5074 in people with severe chronic kidney disease. It involved 11 patients, some on dialysis and some not, to see how they tolerated single doses. The main goal was to gather initial safety information, not to treat the disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
KBP Biosciences USA Inc
Princeton, New Jersey, 08540, United States
Conditions
Explore the condition pages connected to this study.